These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 17021260

  • 1. Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice.
    Damaj MI, Siu EC, Sellers EM, Tyndale RF, Martin BR.
    J Pharmacol Exp Ther; 2007 Jan; 320(1):250-7. PubMed ID: 17021260
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor.
    Alsharari SD, Siu EC, Tyndale RF, Damaj MI.
    Nicotine Tob Res; 2014 Jan; 16(1):18-25. PubMed ID: 23884323
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
    Sellers EM, Kaplan HL, Tyndale RF.
    Clin Pharmacol Ther; 2000 Jul; 68(1):35-43. PubMed ID: 10945314
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
    Zhang W, Kilicarslan T, Tyndale RF, Sellers EM.
    Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
    [Abstract] [Full Text] [Related]

  • 5. Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo.
    Raunio H, Pokela N, Puhakainen K, Rahnasto M, Mauriala T, Auriola S, Juvonen RO.
    Xenobiotica; 2008 Jan; 38(1):34-47. PubMed ID: 18098062
    [Abstract] [Full Text] [Related]

  • 6. Different modes of inhibition of mouse Cyp2a5 and rat CYP2A3 by the food-derived 8-methoxypsoralen.
    Visoni S, Meireles N, Monteiro L, Rossini A, Pinto LF.
    Food Chem Toxicol; 2008 Mar; 46(3):1190-5. PubMed ID: 18215451
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.
    Sellers EM, Ramamoorthy Y, Zeman MV, Djordjevic MV, Tyndale RF.
    Nicotine Tob Res; 2003 Dec; 5(6):891-9. PubMed ID: 14668073
    [Abstract] [Full Text] [Related]

  • 9. Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice.
    Siu EC, Tyndale RF.
    Mol Pharmacol; 2007 Mar; 71(3):826-34. PubMed ID: 17158199
    [Abstract] [Full Text] [Related]

  • 10. Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice.
    Siu EC, Tyndale RF.
    J Pharmacol Exp Ther; 2008 Mar; 324(3):992-9. PubMed ID: 18065502
    [Abstract] [Full Text] [Related]

  • 11. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
    Hukkanen J, Jacob P, Benowitz NL.
    Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
    [Abstract] [Full Text] [Related]

  • 12. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED, Hankins DC, Taraday JK.
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [Abstract] [Full Text] [Related]

  • 13. Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.
    Li L, Jia K, Zhou X, McCallum SE, Hough LB, Ding X.
    J Pharmacol Exp Ther; 2013 Dec; 347(3):746-54. PubMed ID: 24045421
    [Abstract] [Full Text] [Related]

  • 14. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice.
    Takeuchi H, Saoo K, Yokohira M, Ikeda M, Maeta H, Miyazaki M, Yamazaki H, Kamataki T, Imaida K.
    Cancer Res; 2003 Nov 15; 63(22):7581-3. PubMed ID: 14633670
    [Abstract] [Full Text] [Related]

  • 15. Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.
    Rahnasto M, Raunio H, Poso A, Wittekindt C, Juvonen RO.
    J Med Chem; 2005 Jan 27; 48(2):440-9. PubMed ID: 15658857
    [Abstract] [Full Text] [Related]

  • 16. Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5.
    Siu EC, Wildenauer DB, Tyndale RF.
    Psychopharmacology (Berl); 2006 Mar 27; 184(3-4):401-8. PubMed ID: 16485141
    [Abstract] [Full Text] [Related]

  • 17. Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.
    Zhou X, Zhuo X, Xie F, Kluetzman K, Shu YZ, Humphreys WG, Ding X.
    J Pharmacol Exp Ther; 2010 Feb 27; 332(2):578-87. PubMed ID: 19923441
    [Abstract] [Full Text] [Related]

  • 18. Role of human cytochrome P4502A6 in C-oxidation of nicotine.
    Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y.
    Drug Metab Dispos; 1996 Nov 27; 24(11):1212-7. PubMed ID: 8937855
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ, Madan A, Parkinson A.
    Arch Biochem Biophys; 1997 May 01; 341(1):47-61. PubMed ID: 9143352
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of neurotransmitters and steroids on human CYP2A6.
    Higashi E, Nakajima M, Katoh M, Tokudome S, Yokoi T.
    Drug Metab Dispos; 2007 Apr 01; 35(4):508-14. PubMed ID: 17237153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.